Terms: = Leukemia AND YWHAE, P62258, 7531, ENSG00000108953, 14-3-3 epsilon, FLJ45465, MDS, MDCR, KCIP-1, 14-3-3E AND Staging
18 results:
1. Effect of RNA splicing machinery gene mutations on prognosis of patients with mds: A meta-analysis.
Wang X; Song X; Yan X
Medicine (Baltimore); 2019 May; 98(21):e15743. PubMed ID: 31124956
[TBL] [Abstract] [Full Text] [Related]
2. The mds genomics-prognosis symbiosis.
Nazha A
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):270-276. PubMed ID: 30504321
[TBL] [Abstract] [Full Text] [Related]
3. Identification and validation of SRY-box containing gene family member
Zhou JD; Wang YX; Zhang TJ; Li XX; Gu Y; Zhang W; Ma JC; Lin J; Qian J
Clin Epigenetics; 2018; 10():92. PubMed ID: 30002740
[TBL] [Abstract] [Full Text] [Related]
4. High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid leukemia or Myelodysplastic Syndrome.
Han X; Medeiros LJ; Zhang YH; You MJ; Andreeff M; Konopleva M; Bueso-Ramos CE
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S30-8. PubMed ID: 27155969
[TBL] [Abstract] [Full Text] [Related]
5. High serum levels of extracellular vesicles expressing malignancy-related markers are released in patients with various types of hematological neoplastic disorders.
Caivano A; Laurenzana I; De Luca L; La Rocca F; Simeon V; Trino S; D'Auria F; Traficante A; Maietti M; Izzo T; D'Arena G; Mansueto G; Pietrantuono G; Laurenti L; Musto P; Del Vecchio L
Tumour Biol; 2015 Dec; 36(12):9739-52. PubMed ID: 26156801
[TBL] [Abstract] [Full Text] [Related]
6. Established and novel agents for myelodysplastic syndromes.
Sekeres MA; Gerds AT
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):82-9. PubMed ID: 25696839
[TBL] [Abstract] [Full Text] [Related]
7. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions.
Quentin S; Cuccuini W; Ceccaldi R; Nibourel O; Pondarre C; Pagès MP; Vasquez N; Dubois d'Enghien C; Larghero J; Peffault de Latour R; Rocha V; Dalle JH; Schneider P; Michallet M; Michel G; Baruchel A; Sigaux F; Gluckman E; Leblanc T; Stoppa-Lyonnet D; Preudhomme C; Socié G; Soulier J
Blood; 2011 Apr; 117(15):e161-70. PubMed ID: 21325596
[TBL] [Abstract] [Full Text] [Related]
8. Non-intensive treatment with low-dose 5-aza-2'-deoxycytidine (DAC) prior to allogeneic blood SCT of older mds/AML patients.
Lübbert M; Bertz H; Rüter B; Marks R; Claus R; Wäsch R; Finke J
Bone Marrow Transplant; 2009 Nov; 44(9):585-8. PubMed ID: 19363531
[TBL] [Abstract] [Full Text] [Related]
9. Myelodysplastic syndromes: diagnosis and staging.
Malcovati L; Nimer SD
Cancer Control; 2008 Oct; 15 Suppl():4-13. PubMed ID: 18813205
[TBL] [Abstract] [Full Text] [Related]
10. [Analysis and clinical significance of ETV6 rearrangement in myelodysplastic syndromes patients].
Ding BT; Guo NJ; Sun JZ; Gao HM; Wang YS; Chen Y
Zhonghua Xue Ye Xue Za Zhi; 2007 Dec; 28(12):804-7. PubMed ID: 18476590
[TBL] [Abstract] [Full Text] [Related]
11. A comparative review of classification systems in myelodysplastic syndromes (mds).
Bennett JM
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
[TBL] [Abstract] [Full Text] [Related]
12. Myelodysplasic syndromes: a comprehensive review.
Catenacci DV; Schiller GJ
Blood Rev; 2005 Nov; 19(6):301-19. PubMed ID: 15885860
[TBL] [Abstract] [Full Text] [Related]
13. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
Michiels JJ; Thiele J
Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
[TBL] [Abstract] [Full Text] [Related]
14. Magnetic resonance imaging in myelodysplastic syndromes.
Lewis S; Wainscoat JS; Moore NR; Golding SJ
Br J Radiol; 1995 Feb; 68(806):121-7. PubMed ID: 7735740
[TBL] [Abstract] [Full Text] [Related]
15. Infection in myelodysplastic syndromes before evolution into acute non-lymphoblastic leukemia.
Oguma S; Yoshida Y; Uchino H; Okuma M; Maekawa T; Nomura T
Int J Hematol; 1994 Aug; 60(2):129-36. PubMed ID: 7948962
[TBL] [Abstract] [Full Text] [Related]
16. Sea blue histiocytosis: a common abnormality of the bone marrow in myelodysplastic syndromes.
Howard MR; Kesteven PJ
J Clin Pathol; 1993 Nov; 46(11):1030-2. PubMed ID: 8254090
[TBL] [Abstract] [Full Text] [Related]
17. [Second neoplasms as a late complication of the treatment of Hodgkin's disease].
Morales MD; González FA; Villegas A; del Potro E; Díaz Mediavilla J; Martínez R; Alvarez A; Colomé JA
Sangre (Barc); 1992 Dec; 37(6):429-33. PubMed ID: 1293793
[TBL] [Abstract] [Full Text] [Related]
18. The histological characterization of ALIP in the myelodysplastic syndromes.
De Wolf-Peeters C; Stessens R; Desmet V; Tricot G; Verwilghen RL
Pathol Res Pract; 1986 Aug; 181(4):402-7. PubMed ID: 3763479
[TBL] [Abstract] [Full Text] [Related]
